Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.

Ayami KanekoNobuaki KobayashKenji MiuraHiromi MatsumotoKohei SomekawaTomofumi HiroseYukihito KajitaAnna TanakaShuhei TeranishiYu SairenjiHidetoshi KawashimaKentaro YumotoToshinori TsukaharaNobuhiko FukudaRyuichi NishihiraKeisuke WatanabeNobuyuki HoritaYu HaraMakoto KudoNaoki MiyazawaTakeshi Kaneko

Published in: Thoracic cancer (2024)

In real-world practice, CP demonstrated superior PFS compared with CNI. These findings can inform treatment selection in advanced NSCLC.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
primary care
healthcare
locally advanced
tyrosine kinase